Savvy Trades and Investments

[researcher59]

RVP -.14 to 9.25, looks like a speculative buy ahead of earnings due out around 5/15 .... their government syringe contract is ramping up. Q4 adj EPS was around $0.34 up from $0.25 in Q3 after eliminating the preferred stock extinguishment gains. They have new production capacity coming online in Q2.

Of course with vaccinations rates now past their peak, maybe earnings will be in steady decline through 2021. On the other hand, booster shots are likely to become necessary against the COVID variants and to extend immunity, especially since herd immunity is becoming less likely. And with the government sending surplus vaccines to 3rd world nations, they'll probably be sending syringes as well.

I picked up a few shares this morning in the low $9's, but view them as speculative.

Beware the high short interest and recent short attack -

https://seekingalpha.com/news/3685109-retractable-technologies-falls-after-new-short-call-from-bleecker-research